Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07208162 · ClinicalTrials.gov registry record · NA
SHARE Adaptation Intervention for African-American Families
A NA study of Mild Dementia and Moderate Dementia, sponsored by Benjamin Rose Institute on Aging.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07208162: Recruiting NA study of Mild Dementia and Moderate Dementia, sponsored by Benjamin Rose Institute on Aging.
NCT07208162 is a NA study of Mild Dementia and Moderate Dementia that is actively recruiting participants, run by Benjamin Rose Institute on Aging. The registered enrollment target is 120 participants, above the 52-participant average among 5 other Mild Dementia trials with a reported enrollment target (131% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07208162, a NA study of Mild Dementia and Moderate Dementia, is actively recruiting participants, sponsored by Benjamin Rose Institute on Aging.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This project aims to culturally adapt the SHARE program for African-Americans in early-moderate stage dementia and their care partner. Upon completion of the adaptation, a pilot randomized-control trial wil be confucted to compare the adaptaed SHARE program versus usual care.
Primary Outcome
SHARE counselors will report length of each session, and we will determine the number of sessions conducted were within 60-90 minutes - the prescribed treatment protocol.
Conditions Studied
Interventions
- BEHAVIORAL 5+1 Adapted, early-stage dyadic care planning intervention
- BEHAVIORAL Counseling session and printed resources
Study Locations (1)
Ohio
- Benjamin Rose - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-08-19 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT07208162 shows while recruiting
NCT07208162 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 52-participant average among 5 other Mild Dementia trials with a reported enrollment target (131% higher).
The record links to 2 conditions, with Mild Dementia appearing as the primary indexed condition, and to 2 interventions - of which 5+1 Adapted, early-stage dyadic care planning intervention is the first listed.
NCT07208162 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07208162 about?
NCT07208162 is a clinical study titled "SHARE Adaptation Intervention for African-American Families". This project aims to culturally adapt the SHARE program for African-Americans in early-moderate stage dementia and their care partner. Upon completion of the adaptation, a pilot randomized-control trial wil be confucted to compare the adaptaed SHARE program versus usual care.
What is the current status of trial NCT07208162?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-08-19. Estimated completion is 2026-07.
What conditions does trial NCT07208162 study?
This clinical trial studies the following conditions: Mild Dementia, Moderate Dementia.
What interventions are being tested in trial NCT07208162?
The interventions under investigation include: 5+1 Adapted, early-stage dyadic care planning intervention (BEHAVIORAL), Counseling session and printed resources (BEHAVIORAL).
Who is sponsoring clinical trial NCT07208162?
This trial is sponsored by Benjamin Rose Institute on Aging, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07208162 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Pulse Stimulation of the Brain
RECRUITING · NA
-
Activity Tracking, Care Partner Co-participation, Text Reminders, Instructional Education, Video-Guided Physical Rehabilitation, and Exercise
RECRUITING · NA
-
Assessing Cognitive Decline at Home
RECRUITING
-
NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking)
ACTIVE NOT RECRUITING · Phase 2
-
A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI